Target intelligence / Profile preview

G-protein coupled receptor 101 (GPR101)

Target
GPR101
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

G-protein coupled receptor 101 (GPR101) is an orphan Class A G-protein coupled receptor that plays a critical role in growth hormone regulation, energy homeostasis, and inflammation resolution. It is highly expressed in the hypothalamus and pituitary gland, where it exhibits high constitutive activity, stimulating cyclic AMP (cAMP) production via Gs, Gq/11, and G12/13 pathways in the absence of ligands. Overexpression of GPR101, typically caused by microduplications on chromosome Xq26.3, is the primary driver of X-linked acrogigantism (X-LAG), a rare pediatric syndrome characterized by early-onset gigantism, pituitary hyperplasia, and excessive growth hormone and prolactin secretion. Beyond its endocrine functions, GPR101 acts as a high-affinity receptor for the specialized pro-resolving mediator resolvin D5 (RvD5n-3 DPA), regulating leukocyte phagocytosis and promoting the resolution of inflammation. While no FDA-approved drugs currently target GPR101, small-molecule agonists like AA-14 have shown potential in restoring growth hormone axis function and promoting rejuvenation, whereas inverse agonists are actively being researched to treat X-LAG by blocking the receptor's constitutive activity.

Other names
GPCR6PAGH2PITA2Probable G-protein coupled receptor 101
02

Mechanism of action

GPR101 is a constitutively active receptor that couples to Gs, Gq/11, and G12/13 pathways to stimulate cAMP production and intracellular signaling. Agonists like AA-14 and Resolvin D5 (RvD5n-3 DPA) bind to the receptor to activate downstream signaling pathways, while inverse agonists are sought to block its constitutive activity to treat X-linked acrogigantism.

03

Biological functions

Signal transductionHormone secretion regulationInflammation resolutionAppetite controlEnergy homeostasis
04

Disease associations

GigantismAcromegalyObesityInflammationEndometrial cancer
05

Safety considerations

Risk of gigantism or acromegaly due to excessive growth hormone secretionPotential for tumor promotion or cellular proliferationRisk of metabolic dysregulation, insulin resistance, or obesity if receptor activity is lost or blocked
06

Interacting drugs

AA-14

2 more in the full profile.

07

Biomarkers

GPR101 gene duplicationGPR101 expression levelGrowth hormone levelInsulin-like growth factor 1 levelProlactin level

Beyond the preview

Go deeper on G-protein coupled receptor 101 (GPR101).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-protein coupled receptor 101 (GPR101).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call